|
GB929406A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
A process for the production of encapsulated material
|
|
GB929401A
(en)
|
1958-12-22 |
1963-06-19 |
Upjohn Co |
Encapsulated emulsions and processes for their preparation
|
|
GB969808A
(en)
|
1962-06-08 |
1964-09-16 |
Boots Pure Drug Co Ltd |
Anthelmintic compositions and compounds
|
|
IT1148784B
(it)
|
1980-04-09 |
1986-12-03 |
Eurand Spa |
Procedimento per la preparazione di microcapsule in un veicolo liquido
|
|
US4946929A
(en)
|
1983-03-22 |
1990-08-07 |
Massachusetts Institute Of Technology |
Bioerodible articles useful as implants and prostheses having predictable degradation rates
|
|
US4794000A
(en)
|
1987-01-08 |
1988-12-27 |
Synthetic Blood Corporation |
Coacervate-based oral delivery system for medically useful compositions
|
|
US4638045A
(en)
|
1985-02-19 |
1987-01-20 |
Massachusetts Institute Of Technology |
Non-peptide polyamino acid bioerodible polymers
|
|
US4806621A
(en)
|
1986-01-21 |
1989-02-21 |
Massachusetts Institute Of Technology |
Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
|
|
US5804178A
(en)
|
1986-11-20 |
1998-09-08 |
Massachusetts Institute Of Technology |
Implantation of cell-matrix structure adjacent mesentery, omentum or peritoneum tissue
|
|
CA1340581C
(en)
|
1986-11-20 |
1999-06-08 |
Joseph P. Vacanti |
Chimeric neomorphogenesis of organs by controlled cellular implantation using artificial matrices
|
|
US5736372A
(en)
|
1986-11-20 |
1998-04-07 |
Massachusetts Institute Of Technology |
Biodegradable synthetic polymeric fibrous matrix containing chondrocyte for in vivo production of a cartilaginous structure
|
|
US5019379A
(en)
|
1987-07-31 |
1991-05-28 |
Massachusetts Institute Of Technology |
Unsaturated polyanhydrides
|
|
US5110927A
(en)
|
1987-12-31 |
1992-05-05 |
The United States Of America As Represented By The Department Of Health And Human Services |
Prazosin analog with increased selectivity and duration of action
|
|
JP2528706B2
(ja)
|
1988-05-30 |
1996-08-28 |
ゼリア新薬工業株式会社 |
ジヒドロピリジン化合物の製剤組成物
|
|
GB8819110D0
(en)
|
1988-08-11 |
1988-09-14 |
Norsk Hydro As |
Antihypertensive drug & method for production
|
|
US5010167A
(en)
|
1989-03-31 |
1991-04-23 |
Massachusetts Institute Of Technology |
Poly(amide-and imide-co-anhydride) for biological application
|
|
US5019400A
(en)
|
1989-05-01 |
1991-05-28 |
Enzytech, Inc. |
Very low temperature casting of controlled release microspheres
|
|
US5013557A
(en)
|
1989-10-03 |
1991-05-07 |
Warner-Lambert Company |
Taste masking compositions comprising spray dried microcapsules containing sucralfate and methods for preparing same
|
|
WO1992018106A1
(fr)
|
1991-04-16 |
1992-10-29 |
Nippon Shinyaku Co., Ltd. |
Procede de production d'une dispersion solide
|
|
TW209174B
(https=)
|
1991-04-19 |
1993-07-11 |
Takeda Pharm Industry Co Ltd |
|
|
GB9206757D0
(en)
|
1992-03-27 |
1992-05-13 |
Ferring Bv |
Novel peptide receptor ligands
|
|
AU4198793A
(en)
|
1992-07-24 |
1994-01-27 |
Takeda Chemical Industries Ltd. |
Microparticle preparation and production thereof
|
|
US5399665A
(en)
|
1992-11-05 |
1995-03-21 |
Massachusetts Institute Of Technology |
Biodegradable polymers for cell transplantation
|
|
US5512600A
(en)
|
1993-01-15 |
1996-04-30 |
Massachusetts Institute Of Technology |
Preparation of bonded fiber structures for cell implantation
|
|
US5514378A
(en)
|
1993-02-01 |
1996-05-07 |
Massachusetts Institute Of Technology |
Biocompatible polymer membranes and methods of preparation of three dimensional membrane structures
|
|
US5565215A
(en)
|
1993-07-23 |
1996-10-15 |
Massachusettes Institute Of Technology |
Biodegradable injectable particles for imaging
|
|
US5543158A
(en)
|
1993-07-23 |
1996-08-06 |
Massachusetts Institute Of Technology |
Biodegradable injectable nanoparticles
|
|
GB9322014D0
(en)
|
1993-10-26 |
1993-12-15 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
|
SE9401108D0
(sv)
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Ophthalmic composition I
|
|
SE9401109D0
(sv)
|
1994-03-31 |
1994-03-31 |
Leiras Oy |
Opthalmic composition II
|
|
US6074642A
(en)
|
1994-05-02 |
2000-06-13 |
Alexion Pharmaceuticals, Inc. |
Use of antibodies specific to human complement component C5 for the treatment of glomerulonephritis
|
|
GB9412273D0
(en)
|
1994-06-18 |
1994-08-10 |
Univ Nottingham |
Administration means
|
|
IT1271679B
(it)
|
1994-07-18 |
1997-06-04 |
Mediolanum Farmaceutici Srl |
Derivati del fenilcarbammato atti all'impiego come anticolinesterasici
|
|
US6007845A
(en)
|
1994-07-22 |
1999-12-28 |
Massachusetts Institute Of Technology |
Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
|
|
US5716404A
(en)
|
1994-12-16 |
1998-02-10 |
Massachusetts Institute Of Technology |
Breast tissue engineering
|
|
ATE251896T1
(de)
|
1994-12-19 |
2003-11-15 |
Daiichi Seiyaku Co |
Granulat-präparate mit kontinuierlicher freisetzung und verfahren zur herstellung
|
|
GB9501841D0
(en)
|
1995-01-31 |
1995-03-22 |
Co Ordinated Drug Dev |
Improvements in and relating to carrier particles for use in dry powder inhalers
|
|
US6413539B1
(en)
|
1996-10-31 |
2002-07-02 |
Poly-Med, Inc. |
Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
|
|
US6123727A
(en)
|
1995-05-01 |
2000-09-26 |
Massachusetts Institute Of Technology |
Tissue engineered tendons and ligaments
|
|
GB9515182D0
(en)
|
1995-07-24 |
1995-09-20 |
Co Ordinated Drug Dev |
Improvements in and relating to powders for use in dry powder inhalers
|
|
DE69628276T2
(de)
|
1995-07-26 |
2004-04-08 |
Kyowa Hakko Kogyo Co., Ltd. |
Zubereitung von xanthinderivaten als feste dispersion
|
|
JPH11512710A
(ja)
|
1995-09-29 |
1999-11-02 |
メルク エンド カンパニー インコーポレーテッド |
アルファ１ｂアドレナリンレセプターアンタゴニスト
|
|
US5747490A
(en)
|
1995-09-29 |
1998-05-05 |
Merck & Co., Inc. |
Alpha 1b adrenergic receptor antagonists
|
|
US6095148A
(en)
|
1995-11-03 |
2000-08-01 |
Children's Medical Center Corporation |
Neuronal stimulation using electrically conducting polymers
|
|
AU7626496A
(en)
|
1995-12-01 |
1997-06-27 |
Ciba-Geigy Ag |
Heteroaryl compounds
|
|
NZ325248A
(en)
|
1995-12-23 |
1999-09-29 |
Pfizer Res & Dev |
Quinoline and quinazoline compounds useful in therapy
|
|
US5902599A
(en)
|
1996-02-20 |
1999-05-11 |
Massachusetts Institute Of Technology |
Biodegradable polymer networks for use in orthopedic and dental applications
|
|
ES2198579T3
(es)
|
1996-07-01 |
2004-02-01 |
Universiteit Utrecht |
Hidrogeles hidrolizables para liberacion controlada.
|
|
EP0842657A1
(en)
|
1996-11-19 |
1998-05-20 |
OctoPlus B.V. |
Microspheres for controlled release and processes to prepare these microspheres
|
|
US6395302B1
(en)
|
1996-11-19 |
2002-05-28 |
Octoplus B.V. |
Method for the preparation of microspheres which contain colloidal systems
|
|
AU7808198A
(en)
|
1997-06-03 |
1998-12-21 |
Biocryst Pharmaceuticals, Inc. |
Novel compounds useful in the complement, coagulat and kallikrein pathways and method for their preparation
|
|
JPH1123485A
(ja)
|
1997-07-07 |
1999-01-29 |
Tani Denki Kogyo Kk |
基板検査方法及び基板検査装置
|
|
US5837752A
(en)
|
1997-07-17 |
1998-11-17 |
Massachusetts Institute Of Technology |
Semi-interpenetrating polymer networks
|
|
ES2287971T3
(es)
|
1997-08-11 |
2007-12-16 |
Pfizer Products Inc. |
Dispersiones farmaceuticas solidas con biodisponibilidad incrementada.
|
|
US6632922B1
(en)
|
1998-03-19 |
2003-10-14 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6686446B2
(en)
|
1998-03-19 |
2004-02-03 |
The Regents Of The University Of California |
Methods and compositions for controlled polypeptide synthesis
|
|
US6506577B1
(en)
|
1998-03-19 |
2003-01-14 |
The Regents Of The University Of California |
Synthesis and crosslinking of catechol containing copolypeptides
|
|
NZ507760A
(en)
|
1998-03-26 |
2002-10-25 |
Japan Tobacco Inc |
Amide derivatives and nociceptin antagonists
|
|
AU1705100A
(en)
|
1998-10-09 |
2000-05-01 |
Musc Foundation For Research Development |
Blocking factor b to treat complement-mediated immune disease
|
|
GB9827145D0
(en)
|
1998-12-09 |
1999-02-03 |
Co Ordinated Drug Dev |
Improvements in or relating to powders
|
|
JP2000281660A
(ja)
|
1999-03-29 |
2000-10-10 |
Sumitomo Pharmaceut Co Ltd |
キナゾリン誘導体
|
|
US6287588B1
(en)
|
1999-04-29 |
2001-09-11 |
Macromed, Inc. |
Agent delivering system comprised of microparticle and biodegradable gel with an improved releasing profile and methods of use thereof
|
|
IT1312310B1
(it)
|
1999-05-07 |
2002-04-15 |
Recordati Ind Chimica E Farma |
Uso di antagonisti selettivi del recettore adrenergico a 1b per ilmiglioramento della disfunzione sessuale
|
|
GB9927011D0
(en)
|
1999-11-16 |
2000-01-12 |
Advanced Phytonics Ltd |
Method for the production of particles
|
|
EP1239844B1
(en)
|
1999-12-20 |
2005-06-08 |
Nicholas J. Kerkhof |
Process for producing nanometer particles by fluid bed spray-drying
|
|
EP1967185A1
(en)
|
1999-12-23 |
2008-09-10 |
Pfizer Products Inc. |
Hydrogel-driven drug dosage form
|
|
CN1402629A
(zh)
|
1999-12-23 |
2003-03-12 |
辉瑞产品公司 |
提供提高的药物浓度的药物组合物
|
|
JP4751556B2
(ja)
|
2000-02-28 |
2011-08-17 |
ジーンシーグス， インコーポレイテッド |
ナノカプセルカプセル化システムおよび方法
|
|
AU2001240150A1
(en)
|
2000-03-13 |
2001-09-24 |
Chemrx Advanced Technologies, Inc. |
Quinazoline synthesis
|
|
WO2001074400A1
(en)
|
2000-04-03 |
2001-10-11 |
Santen Pharmaceutical Co., Ltd. |
Transporters and drug delivery system by using the same
|
|
GB0009469D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formalities for use in inhaler devices
|
|
GB0009468D0
(en)
|
2000-04-17 |
2000-06-07 |
Vectura Ltd |
Improvements in or relating to formulations for use in inhaler devices
|
|
US6589549B2
(en)
|
2000-04-27 |
2003-07-08 |
Macromed, Incorporated |
Bioactive agent delivering system comprised of microparticles within a biodegradable to improve release profiles
|
|
US6495164B1
(en)
|
2000-05-25 |
2002-12-17 |
Alkermes Controlled Therapeutics, Inc. I |
Preparation of injectable suspensions having improved injectability
|
|
JP5698423B2
(ja)
|
2000-06-27 |
2015-04-08 |
ベクトゥラ・リミテッド |
医薬組成物で使用するための粒子の製造法
|
|
GB2364919A
(en)
|
2000-07-21 |
2002-02-13 |
Cambridge Consultants |
Inhalers
|
|
GB0021024D0
(en)
|
2000-08-29 |
2000-10-11 |
Glaxo Group Ltd |
Inhalation device
|
|
CN1507357A
(zh)
|
2000-10-31 |
2004-06-23 |
PRҩƷ����˾ |
提高生物活性分子传递的方法和组合物
|
|
DE60140268D1
(de)
|
2000-11-30 |
2009-12-03 |
Vectura Ltd |
Partikel zur verwendung in einer pharmazeutischen zusammensetzung
|
|
WO2003020797A1
(en)
|
2001-08-30 |
2003-03-13 |
The Regents Of The University Of California |
Transition metal initiators for controlled poly (beta-peptide) synthesis from beta-lactam monomers
|
|
GB0122318D0
(en)
|
2001-09-14 |
2001-11-07 |
Novartis Ag |
Organic compounds
|
|
WO2003063831A2
(en)
|
2002-02-01 |
2003-08-07 |
Pfizer Products Inc. |
Immediate release dosage forms containing solid drug dispersions
|
|
WO2004045518A2
(en)
|
2002-11-15 |
2004-06-03 |
Bristol-Myers Squibb Company |
Open chain prolyl urea-related modulators of androgen receptor function
|
|
US20050009910A1
(en)
|
2003-07-10 |
2005-01-13 |
Allergan, Inc. |
Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
|
|
JP2007505831A
(ja)
|
2003-09-15 |
2007-03-15 |
ベクトゥラ・リミテッド |
肺吸入による、早漏を治療するための医薬品組成物
|
|
KR20060085246A
(ko)
|
2003-09-18 |
2006-07-26 |
마커사이트, 인코포레이티드 |
경공막 전달
|
|
EP1694731B1
(en)
|
2003-09-23 |
2012-03-28 |
University Of North Carolina At Chapel Hill |
Photocurable perfluoropolyethers for use as novel materials in microfluidic devices
|
|
SE0302665D0
(sv)
|
2003-10-07 |
2003-10-07 |
Astrazeneca Ab |
Novel Process
|
|
WO2005044186A2
(en)
|
2003-10-28 |
2005-05-19 |
Glaxo Group Limited |
Inhalable pharmaceutical formulations employing desiccating agents and methods of administering the same
|
|
MXPA06006738A
(es)
|
2003-12-19 |
2006-08-31 |
Univ North Carolina |
Metodos para fabricar micro- y nano-estructuras aisladas utilizando litografia suave o de impresion.
|
|
EP1713514B1
(en)
|
2004-01-28 |
2021-11-24 |
Johns Hopkins University |
Drugs and gene carrier particles that rapidly move through mucous barriers
|
|
GB0407627D0
(en)
|
2004-04-02 |
2004-05-05 |
Vectura Ltd |
Corkscrew pump
|
|
TWI380816B
(zh)
|
2004-04-13 |
2013-01-01 |
Synta Pharmaceuticals Corp |
抑制介白素-１２（ｉｌ-１２）生成之二鹽抑制劑
|
|
ES2246694B1
(es)
|
2004-04-29 |
2007-05-01 |
Instituto Cientifico Y Tecnologico De Navarra, S.A. |
Nanoparticulas pegiladas.
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
US7771742B2
(en)
|
2004-04-30 |
2010-08-10 |
Allergan, Inc. |
Sustained release intraocular implants containing tyrosine kinase inhibitors and related methods
|
|
WO2005107708A1
(en)
|
2004-04-30 |
2005-11-17 |
Allergan, Inc. |
Biodegradable intravitreal tyrosine kinase inhibitors implants
|
|
JP2007269629A
(ja)
|
2004-06-21 |
2007-10-18 |
Astellas Pharma Inc |
キナゾリン誘導体
|
|
PL370285A1
(pl)
|
2004-09-23 |
2006-04-03 |
Glaxosmithkline Pharmaceuticals Spółka Akcyjna |
Inhalator proszkowy
|
|
CA2594694A1
(en)
|
2005-01-28 |
2006-08-03 |
Pfizer Products Inc. |
Drying of drug-containing particles
|
|
WO2006082518A1
(en)
|
2005-02-03 |
2006-08-10 |
Pfizer Products Inc. |
Pharmaceutical compositions with enhanced performance
|
|
DK1848431T3
(en)
|
2005-02-09 |
2016-04-18 |
Santen Pharmaceutical Co Ltd |
LIQUID FORMULATIONS FOR TREATMENT OF DISEASES OR CONDITIONS
|
|
US8663639B2
(en)
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
CN102016814B
(zh)
|
2005-06-17 |
2013-10-23 |
北卡罗来纳大学查珀尔希尔分校 |
纳米粒子制备方法、系统及材料
|
|
EP2537657A3
(en)
|
2005-08-09 |
2016-05-04 |
The University of North Carolina At Chapel Hill |
Methods and materials for fabricating microfluidic devices
|
|
US20070071756A1
(en)
|
2005-09-26 |
2007-03-29 |
Peyman Gholam A |
Delivery of an agent to ameliorate inflammation
|
|
WO2007056561A2
(en)
|
2005-11-09 |
2007-05-18 |
Liquidia Technologies, Inc. |
Medical device, materials, and methods
|
|
KR20080089416A
(ko)
|
2005-12-21 |
2008-10-06 |
페인셉터 파마 코포레이션 |
개폐 이온 통로를 조절하기 위한 조성물 및 방법
|
|
EP1962803A1
(en)
|
2005-12-23 |
2008-09-03 |
Alcon, Inc. |
PHARMACEUTICAL FORMULATION FOR DELIVERY OF RECEPTOR TYROSINE KINASE INHIBITING (RTKi) COMPOUNDS TO THE EYE
|
|
WO2007081876A2
(en)
|
2006-01-04 |
2007-07-19 |
Liquidia Technologies, Inc. |
Nanostructured surfaces for biomedical/biomaterial applications and processes thereof
|
|
JP5819579B2
(ja)
|
2006-01-13 |
2015-11-24 |
サーモディクス，インコーポレイティド |
薬物送達のためのマトリックスを含む微粒子
|
|
ES2563288T3
(es)
|
2006-03-23 |
2016-03-14 |
Santen Pharmaceutical Co., Ltd |
Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
|
|
US20080166411A1
(en)
|
2006-04-10 |
2008-07-10 |
Pfizer Inc |
Injectable Depot Formulations And Methods For Providing Sustained Release Of Poorly Soluble Drugs Comprising Nanoparticles
|
|
WO2007133808A2
(en)
|
2006-05-15 |
2007-11-22 |
Liquidia Technologies, Inc. |
Nano-particles for cosmetic applications
|
|
AU2007271187A1
(en)
|
2006-07-03 |
2008-01-10 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Fused bicyclic compounds interacting with the histamine H4 receptor
|
|
WO2008013952A2
(en)
|
2006-07-27 |
2008-01-31 |
The University Of North Carolina At Chapel Hill |
Nanoparticle fabrication methods, systems, and materials for fabricating artificial red blood cells
|
|
GB0617480D0
(en)
|
2006-09-06 |
2006-10-18 |
Univ Sheffield |
Novel nanoparticles
|
|
EP2061433B1
(en)
|
2006-09-08 |
2011-02-16 |
Johns Hopkins University |
Compositions for enhancing transport through mucus
|
|
US9022970B2
(en)
|
2006-10-16 |
2015-05-05 |
Alcon Research, Ltd. |
Ophthalmic injection device including dosage control device
|
|
WO2008067127A2
(en)
|
2006-11-09 |
2008-06-05 |
Alcon Research, Ltd. |
Water insoluble polymer matrix for drug delivery
|
|
US20100216928A1
(en)
|
2006-11-15 |
2010-08-26 |
The University of North Carolona at Chapel Hill |
Polymer particle composite having high fidelity order, size, and shape particles
|
|
JP5332064B2
(ja)
|
2007-03-01 |
2013-11-06 |
ウェルスタット イムノセラピューティクス， エルエルシー |
炎症により特徴付けられる疾患の治療
|
|
JP2011500569A
(ja)
|
2007-10-12 |
2011-01-06 |
マサチューセッツ インスティテュート オブ テクノロジー |
ワクチンナノテクノロジー
|
|
WO2009100176A2
(en)
|
2008-02-07 |
2009-08-13 |
Abbott Laboratories |
Pharmaceutical dosage form for oral administration of tyrosine kinase inhibitor
|
|
US9943401B2
(en)
|
2008-04-04 |
2018-04-17 |
Eugene de Juan, Jr. |
Therapeutic device for pain management and vision
|
|
WO2009132206A1
(en)
|
2008-04-25 |
2009-10-29 |
Liquidia Technologies, Inc. |
Compositions and methods for intracellular delivery and release of cargo
|
|
WO2009132265A2
(en)
|
2008-04-25 |
2009-10-29 |
The University Of North Carolina At Chapel Hill |
Degradable compounds and methods of use thereof, particularly with particle replication in non-wetting templates
|
|
EP2133334A1
(en)
|
2008-06-09 |
2009-12-16 |
DAC S.r.l. |
Heterocyclic derivatives as HDAC inhibitors
|
|
WO2010009087A1
(en)
|
2008-07-15 |
2010-01-21 |
Eyegate Pharmaceuticals, Inc. |
Iontophoretic delivery of a controlled-release formulation in the eye
|
|
CA2738822A1
(en)
|
2008-10-08 |
2010-04-15 |
Astrazeneca Ab |
Inhalation device and method of dispensing medicament
|
|
KR101690643B1
(ko)
|
2008-12-05 |
2016-12-28 |
리퀴디아 테크놀로지스 인코포레이티드 |
패턴 재료 제조 방법
|
|
AU2009335094B2
(en)
|
2008-12-30 |
2012-11-15 |
Hill's Pet Nutrition, Inc. |
Use of lipoic acid for treating or preventing degenerative joint conditions, osteoarthritis, cartilage damage, and related disorders in companion animals
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
AU2010208046B2
(en)
|
2009-01-29 |
2014-10-02 |
Forsight Vision4, Inc. |
Posterior segment drug delivery
|
|
WO2010091187A2
(en)
|
2009-02-04 |
2010-08-12 |
The Brigham And Women's Hospital, Inc. |
Polymeric nanoparticles with enhanced drug-loading and methods of use thereof
|
|
RU2528412C2
(ru)
*
|
2009-02-10 |
2014-09-20 |
Янссен Фармацевтика Нв |
Хиназолиноны как ингибиторы пролилгидроксилазы
|
|
WO2010093662A2
(en)
|
2009-02-10 |
2010-08-19 |
Psivida Us, Inc. |
Ocular trocar assembly
|
|
KR101674904B1
(ko)
|
2009-02-26 |
2016-11-10 |
더 유니버시티 오브 노쓰 캐롤라이나 엣 채플 힐 |
중재형 약물전달 시스템과 그 방법
|
|
US10952965B2
(en)
|
2009-05-15 |
2021-03-23 |
Baxter International Inc. |
Compositions and methods for drug delivery
|
|
EP2437684B1
(en)
|
2009-06-03 |
2022-06-15 |
ForSight Vision5, Inc. |
Anterior segment drug delivery
|
|
JP5656996B2
(ja)
|
2009-07-13 |
2015-01-21 |
ザ ユニバーシティ オブ ノース キャロライナ アット チャペル ヒル |
工学的に作製されたエアロゾル粒子、およびそれに関連した方法
|
|
TWI492769B
(zh)
|
2009-09-23 |
2015-07-21 |
Alcon Res Ltd |
可注射的水性眼用組成物及其使用之方法
|
|
US20130066283A1
(en)
|
2009-10-23 |
2013-03-14 |
Nexisvision, Inc. |
Corneal Denervation for Treatment of Ocular Pain
|
|
EP2490620A4
(en)
|
2009-10-23 |
2017-03-22 |
Forsight Labs, Llc |
Conformable therapeutic shield for vision and pain
|
|
TWI478730B
(zh)
|
2009-12-03 |
2015-04-01 |
Alcon Res Ltd |
眼科乳劑
|
|
WO2013022801A1
(en)
|
2011-08-05 |
2013-02-14 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
WO2011106702A2
(en)
|
2010-02-25 |
2011-09-01 |
The Johns Hopkins University |
Sustained delivery of therapeutic agents to an eye compartment
|
|
WO2011109384A2
(en)
|
2010-03-02 |
2011-09-09 |
Allergan, Inc. |
Biodegradable polymers for lowering intraocular pressure
|
|
CA2798069C
(en)
|
2010-05-05 |
2016-07-05 |
Howard Allen Ketelson |
Stabilized ophthalmic galactomannan formulations
|
|
US8999312B2
(en)
|
2010-06-02 |
2015-04-07 |
Alcon Research, Ltd. |
Use of PBO-PEO-PBO block copolymers in ophthalmic compositions
|
|
EP3861969A1
(en)
|
2010-08-05 |
2021-08-11 |
ForSight Vision4, Inc. |
Injector apparatus for drug delivery
|
|
AU2011285548B2
(en)
|
2010-08-05 |
2014-02-06 |
Forsight Vision4, Inc. |
Combined drug delivery methods and apparatus
|
|
CN103209664A
(zh)
|
2010-08-05 |
2013-07-17 |
弗赛特影像4股份有限公司 |
可植入的治疗装置
|
|
CA2807508A1
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision4, Inc. |
Subconjunctival implant for posterior segment drug delivery
|
|
EP2611529B1
(en)
|
2010-09-03 |
2019-01-23 |
Bend Research, Inc. |
Spray-drying method
|
|
US10307372B2
(en)
|
2010-09-10 |
2019-06-04 |
The Johns Hopkins University |
Rapid diffusion of large polymeric nanoparticles in the mammalian brain
|
|
WO2012061703A1
(en)
|
2010-11-05 |
2012-05-10 |
The Johns Hopkins University |
Compositions and methods relating to reduced mucoadhesion
|
|
US20140033800A1
(en)
|
2010-11-11 |
2014-02-06 |
Forsight Vision4, Inc. |
Methods and apparatus to determine diffusion properties of porous structures for drug delivery
|
|
TW201304822A
(zh)
|
2010-11-15 |
2013-02-01 |
Vectura Ltd |
組成物及用途
|
|
WO2012068549A2
(en)
|
2010-11-19 |
2012-05-24 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
PT2661433T
(pt)
|
2011-01-04 |
2017-10-24 |
Novartis Ag |
Compostos de indole ou seus análogos úteis para o tratamento da degeneração macular relacionada com a idade (amd)
|
|
WO2012109363A2
(en)
|
2011-02-08 |
2012-08-16 |
The Johns Hopkins University |
Mucus penetrating gene carriers
|
|
WO2012145801A1
(en)
|
2011-04-29 |
2012-11-01 |
Jagat Rakesh Kanwar |
Nanoparticle
|
|
EP2704744B1
(en)
|
2011-05-05 |
2019-04-24 |
Wellstat ImmunoTherapeutics, LLC |
Complement factor b analogs and their uses
|
|
US9060938B2
(en)
|
2011-05-10 |
2015-06-23 |
Bend Research, Inc. |
Pharmaceutical compositions of active agents and cationic dextran polymer derivatives
|
|
US8691750B2
(en)
|
2011-05-17 |
2014-04-08 |
Axolabs Gmbh |
Lipids and compositions for intracellular delivery of biologically active compounds
|
|
MX2012007705A
(es)
|
2011-06-29 |
2012-12-28 |
Rehrig Pacific Co |
Caja con pared retractil.
|
|
JP5721197B2
(ja)
|
2011-06-29 |
2015-05-20 |
Ｎｅｃソリューションイノベータ株式会社 |
三次元地物データ生成装置、三次元地物データ生成方法、および、三次元地物データ生成プログラム
|
|
GB201115874D0
(en)
|
2011-09-14 |
2011-10-26 |
Astrazeneca Ab |
Inhaler
|
|
JP5989780B2
(ja)
|
2011-09-14 |
2016-09-07 |
フォーサイト・ビジョン５・インコーポレイテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ５，Ｉｎｃ． |
眼挿入装置および方法
|
|
PT2755600T
(pt)
|
2011-09-16 |
2021-04-19 |
Forsight Vision4 Inc |
Aparelhos de troca de fluidos
|
|
WO2013082111A2
(en)
|
2011-11-29 |
2013-06-06 |
The University Of North Carolina At Chapel Hill |
Geometrically engineered particles and methods for modulating macrophage or immune responses
|
|
BR112014014262A2
(pt)
|
2011-12-14 |
2017-06-13 |
Univ Johns Hopkins |
nanopartículas; composição farmacêutica; método de administrar um ou mais agentes terapêuticos, profiláticos, e/ou diagnósticos a um paciente em necessidade dos mesmos e método de preparação das partículas.
|
|
CN102516232A
(zh)
|
2011-12-14 |
2012-06-27 |
无锡美克赛医药科技有限公司 |
一种ErbB2的小分子选择性抑制剂及其应用
|
|
PT2797652T
(pt)
|
2011-12-27 |
2019-02-19 |
Vectura Gmbh |
Dispositivo para inalação com sistema de feedback
|
|
EP2724741B1
(en)
|
2012-10-26 |
2017-06-14 |
Vectura GmbH |
Inhalation device for use in aerosol therapy
|
|
EP2804632B1
(en)
|
2012-01-19 |
2019-09-18 |
The Johns Hopkins University |
Nanoparticle formulations with enhanced mucosal penetration
|
|
WO2013116061A1
(en)
|
2012-02-03 |
2013-08-08 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
EP2846859B1
(en)
|
2012-03-09 |
2017-01-04 |
Vectura GmbH |
Mixing channel for an inhalation device and inhalation device
|
|
JP6138904B2
(ja)
|
2012-03-16 |
2017-05-31 |
ザ・ジョンズ・ホプキンス・ユニバーシティー |
活性剤の送達のための非線状マルチブロックコポリマー薬物コンジュゲート
|
|
US8962577B2
(en)
|
2012-03-16 |
2015-02-24 |
The Johns Hopkins University |
Controlled release formulations for the delivery of HIF-1 inhibitors
|
|
US20140107025A1
(en)
|
2012-04-16 |
2014-04-17 |
Jade Therapeutics, Llc |
Ocular drug delivery system
|
|
ES3055223T3
(en)
|
2012-05-03 |
2026-02-10 |
Alcon Inc |
Pharmaceutical nanoparticles showing improved mucosal transport
|
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
|
JP6360039B2
(ja)
|
2012-05-03 |
2018-07-18 |
カラ ファーマシューティカルズ インコーポレイテッド |
複数の被覆された粒子を含む組成物、医薬組成物、医薬製剤、及び当該粒子の形成方法
|
|
AU2013256008B2
(en)
|
2012-05-04 |
2016-02-25 |
The Johns Hopkins University |
Lipid-based drug carriers for rapid penetration through mucus linings
|
|
EA027113B1
(ru)
|
2012-05-04 |
2017-06-30 |
Новартис Аг |
Регуляторы пути комплемента и их применение
|
|
EA201590053A1
(ru)
*
|
2012-06-20 |
2015-08-31 |
Новартис Аг |
Модуляторы пути системы комплемента и их применение
|
|
CN104379579B
(zh)
|
2012-06-28 |
2017-03-08 |
诺华股份有限公司 |
吡咯烷衍生物及其作为补体途径调节剂的用途
|
|
WO2014002058A2
(en)
|
2012-06-28 |
2014-01-03 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
EP2867225B1
(en)
|
2012-06-28 |
2017-08-09 |
Novartis AG |
Pyrrolidine derivatives and their use as complement pathway modulators
|
|
US9815819B2
(en)
|
2012-06-28 |
2017-11-14 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
ES2644700T3
(es)
|
2012-06-28 |
2017-11-30 |
Novartis Ag |
Derivados de pirrolidina y su uso como moduladores de la ruta del complemento
|
|
MX2014015738A
(es)
|
2012-06-28 |
2015-08-06 |
Novartis Ag |
Derivados de pirrolidina y su uso como moduladores de la senda del complemento.
|
|
WO2014002059A1
(en)
|
2012-06-29 |
2014-01-03 |
Novartis Ag |
CRYSTALLINE FORMS OF 1-(2-((1R,3S,5R)-3-(((R)-1-(3-chloro-2-fluorophenyl)ethyl)carbamoyl)-2-azabicyclo[3.1.0]hexan-2-yl)-2-oxoethyl)-1Hpyrazolo[3,4-c]pyridine-3-carboxamide
|
|
WO2014005150A1
(en)
|
2012-06-29 |
2014-01-03 |
Novartis Ag |
Crystalline forms of l-(2-((lr,3s,5r)-3-( (2 -fluoro-3 - (trifluoromethoxy) phenyl) carbamoyl) - 2 -azabicycl o [3.1.0] hexan- 2 -yl) - 2 -oxoethyl) - 5 -methyl - 1h - pyrazolo [3, 4 -c] pyridine - 3 - carboxami de and salts thereof
|
|
CA2882724A1
(en)
|
2012-07-12 |
2014-01-16 |
Novartis Ag |
Complement pathway modulators and uses thereof
|
|
ES1077714Y
(es)
|
2012-07-31 |
2012-12-20 |
Gutierrez Jose Ramon Perez |
Envase de madera
|
|
WO2014035876A1
(en)
|
2012-08-27 |
2014-03-06 |
William Marsh Rice University |
Heat-inactivated complement factor b compositions and methods
|
|
EP2895146A1
(en)
|
2012-09-17 |
2015-07-22 |
BIND Therapeutics, Inc. |
Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same
|
|
KR20150090038A
(ko)
|
2012-09-20 |
2015-08-05 |
아키나, 인크. |
충전재를 함유한 생분해성 미세캡슐
|
|
RU2652063C2
(ru)
|
2012-10-26 |
2018-04-24 |
Форсайт Вижн5, Инк. |
Офтальмологическая система для замедленного высвобождения лекарственного средства в глазу
|
|
WO2014152959A1
(en)
|
2013-03-14 |
2014-09-25 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US9475806B2
(en)
|
2013-03-14 |
2016-10-25 |
Novartis Ag |
Complement factor B inhibitors and uses there of
|
|
CN105246438B
(zh)
|
2013-03-28 |
2018-01-26 |
弗赛特影像4股份有限公司 |
用于输送治疗物质的眼科植入物
|
|
AU2014248460B2
(en)
|
2013-04-01 |
2019-04-11 |
Allergan, Inc. |
Microsphere drug delivery system for sustained intraocular release
|
|
JO3425B1
(ar)
|
2013-07-15 |
2019-10-20 |
Novartis Ag |
مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b
|
|
KR20160036568A
(ko)
|
2013-07-18 |
2016-04-04 |
노파르티스 아게 |
보체 인자 d 억제제로서의 아미노메틸-비아릴 유도체 및 그의 용도
|
|
MY181251A
(en)
|
2013-09-13 |
2020-12-21 |
Ionis Pharmaceuticals Inc |
Modulators of complement factor b
|
|
EP3057514A4
(en)
|
2013-10-15 |
2017-08-02 |
Forsight Vision5, Inc. |
Formulations and methods for increasing or reducing mucus
|
|
CN105849090A
(zh)
|
2013-10-30 |
2016-08-10 |
诺华股份有限公司 |
2-苄基-苯并咪唑补体因子b抑制剂及其用途
|
|
US20160296627A1
(en)
|
2013-12-06 |
2016-10-13 |
Envisia Therapeutics Inc. |
Intracameral implant for treatment of an ocular condition
|
|
WO2015085234A1
(en)
|
2013-12-06 |
2015-06-11 |
Forsight Vision4, Inc. |
Implantable therapeutic devices
|
|
SG11201811491YA
(en)
*
|
2016-06-27 |
2019-01-30 |
Achillion Pharmaceuticals Inc |
Quinazoline and indole compounds to treat medical disorders
|